In particular, there was a statistically significant increase in CD4, CD14, CD68, CD8A, B7-H3, PDL-1, CD19, FOXP3, CD44, and STAT3 protein expression in methylated versus unmethylated GBM tumour core (see Table 2). This evidence concerns the gene CD8A and glioblastoma.